- Home
- CCSI vs AQST Comparison
CCSI vs AQST Comparison
Compare CCSI & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCSI
- AQST
- Stock Information
- Founded
- CCSI 2021
- AQST 2004
- Country
- CCSI United States
- AQST United States
- Employees
- CCSI N/A
- AQST N/A
- Industry
- CCSI Retail: Computer Software & Peripheral Equipment
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- CCSI Technology
- AQST Health Care
- Exchange
- CCSI Nasdaq
- AQST Nasdaq
- Market Cap
- CCSI 450.6M
- AQST 390.4M
- IPO Year
- CCSI N/A
- AQST 2018
- Fundamental
- Price
- CCSI $26.93
- AQST $4.88
- Analyst Decision
- CCSI Hold
- AQST Strong Buy
- Analyst Count
- CCSI 5
- AQST 7
- Target Price
- CCSI $27.20
- AQST $10.29
- AVG Volume (30 Days)
- CCSI 126.9K
- AQST 2.6M
- Earning Date
- CCSI 11-06-2025
- AQST 11-03-2025
- Dividend Yield
- CCSI N/A
- AQST N/A
- EPS Growth
- CCSI N/A
- AQST N/A
- EPS
- CCSI 4.15
- AQST N/A
- Revenue
- CCSI $349,595,000.00
- AQST $44,132,000.00
- Revenue This Year
- CCSI $1.55
- AQST N/A
- Revenue Next Year
- CCSI $1.10
- AQST $38.71
- P/E Ratio
- CCSI $6.54
- AQST N/A
- Revenue Growth
- CCSI N/A
- AQST N/A
- 52 Week Low
- CCSI $17.84
- AQST $2.12
- 52 Week High
- CCSI $32.10
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- CCSI 61.34
- AQST 63.86
- Support Level
- CCSI $26.82
- AQST $4.75
- Resistance Level
- CCSI $27.82
- AQST $5.60
- Average True Range (ATR)
- CCSI 0.73
- AQST 0.29
- MACD
- CCSI -0.06
- AQST 0.12
- Stochastic Oscillator
- CCSI 68.31
- AQST 61.23
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.